サマリー

甲状腺機能亢進症向け抗甲状腺薬の世界市場規模は、2022年の4億4310万米ドルから2029年には6億8740万米ドルに成長すると予測され、2023年から2029年までのCAGRは6.5%と予測されています。
甲状腺機能亢進症向け抗甲状腺薬の米国市場は、2023年から2029年までのCAGRで、2022年の100万米ドルから2029年には100万米ドルに増加すると予測されています。
甲状腺機能亢進症治療薬の中国市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
甲状腺機能亢進症治療薬のヨーロッパ市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年までに百万米ドルに増加すると推定されます。
甲状腺機能亢進症のための抗甲状腺薬の世界的な主要プレーヤーは、メルク、Herbrand PharmaChemicals、Future Health Pharma、上海Zhaohui Pharmaceutical、Beijing Yanjing Pharmaceutical、Jinghua Pharmaceutical Group、広州Kanghe Pharmaceutical、Zigong Honghe Pharmaceutical、Guangdong Huanan Pharmaceuticalなど。売上高では、2022年に世界の2大企業がほぼ％のシェアを占めています。
抗甲状腺薬は、甲状腺ホルモンが過剰に分泌される甲状腺機能亢進症の治療に使用される薬です。この薬は、甲状腺における甲状腺ホルモンの産生を阻害することで効果を発揮します。
LPI（エルピーアイ）の最新調査レポート「甲状腺機能亢進症の抗甲状腺薬産業予測」は、過去の売上高を調べ、2022年の世界の甲状腺機能亢進症の抗甲状腺薬総売上高を検討し、2023年から2029年の予想甲状腺機能亢進症売上高の地域・市場分野別の総合分析を提供しています。甲状腺機能亢進症治療薬の売上を地域別、市場分野別、サブセクター別に分類し、世界の甲状腺機能亢進症治療薬産業の詳細な分析（百万米ドル単位）を提供します。
本インサイトレポートでは、世界の甲状腺機能亢進症向け抗甲状腺薬の状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにします。また、本レポートでは、加速する世界の甲状腺機能亢進症治療薬市場におけるこれらの企業の独自のポジションをより良く理解するために、甲状腺機能亢進症治療薬のポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当てて、主要グローバル企業の戦略を分析しています。
本インサイトレポートでは、甲状腺機能亢進症治療薬の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、本調査予測は、世界の甲状腺機能亢進症治療薬の現状と将来の軌道について非常にニュアンスのある見方を提供します。
本レポートでは、製品タイプ、用途、主要メーカー、主要地域・国別の甲状腺機能亢進症治療薬市場の包括的な概要、市場シェア、および成長機会を紹介します。
市場のセグメンテーション
タイプ別セグメンテーション
メチマゾール
プロピルチオウラシル
その他
アプリケーション別セグメント
病院
クリニック
その他
また、本レポートでは、市場を地域別に分類しています：
米州
ユーエスエー
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
連邦王国
イタリア
ロシア
中近東・アフリカ
エジプト
南ア
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した上で選ばれています。
メルク
ハーブランド ファーマケミカルズ
フューチャーヘルスファーマ
上海招牌医薬有限公司
北京燕京製薬
金華製薬グループ
広州康河医薬有限公司
紫紺紅河製薬
広東華南製薬
淄博万康医薬化学
斉魯薬業
本レポートで扱う主な質問
世界の甲状腺機能亢進症治療薬市場の10年後の展望は？
世界および地域別に、甲状腺機能亢進症治療薬の市場成長を促進する要因は何か？
市場別、地域別に最も早く成長するのはどの技術か？
甲状腺機能亢進症治療薬の市場機会は、エンドマーケットの規模によってどのように変化するか？
甲状腺機能亢進症治療薬のタイプ別、用途別内訳は？
COVID-19とロシア・ウクライナ戦争の影響とは？

ページTOPに戻る

目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antithyroid Medications for Hyperthyroidism Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Antithyroid Medications for Hyperthyroidism by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Antithyroid Medications for Hyperthyroidism by Country/Region, 2018, 2022 & 2029
2.2 Antithyroid Medications for Hyperthyroidism Segment by Type
2.2.1 Methimazole
2.2.2 Propylthiouracil
2.2.3 Other
2.3 Antithyroid Medications for Hyperthyroidism Sales by Type
2.3.1 Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Type (2018-2023)
2.3.2 Global Antithyroid Medications for Hyperthyroidism Revenue and Market Share by Type (2018-2023)
2.3.3 Global Antithyroid Medications for Hyperthyroidism Sale Price by Type (2018-2023)
2.4 Antithyroid Medications for Hyperthyroidism Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Antithyroid Medications for Hyperthyroidism Sales by Application
2.5.1 Global Antithyroid Medications for Hyperthyroidism Sale Market Share by Application (2018-2023)
2.5.2 Global Antithyroid Medications for Hyperthyroidism Revenue and Market Share by Application (2018-2023)
2.5.3 Global Antithyroid Medications for Hyperthyroidism Sale Price by Application (2018-2023)
3 Global Antithyroid Medications for Hyperthyroidism by Company
3.1 Global Antithyroid Medications for Hyperthyroidism Breakdown Data by Company
3.1.1 Global Antithyroid Medications for Hyperthyroidism Annual Sales by Company (2018-2023)
3.1.2 Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Company (2018-2023)
3.2 Global Antithyroid Medications for Hyperthyroidism Annual Revenue by Company (2018-2023)
3.2.1 Global Antithyroid Medications for Hyperthyroidism Revenue by Company (2018-2023)
3.2.2 Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Company (2018-2023)
3.3 Global Antithyroid Medications for Hyperthyroidism Sale Price by Company
3.4 Key Manufacturers Antithyroid Medications for Hyperthyroidism Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antithyroid Medications for Hyperthyroidism Product Location Distribution
3.4.2 Players Antithyroid Medications for Hyperthyroidism Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Antithyroid Medications for Hyperthyroidism by Geographic Region
4.1 World Historic Antithyroid Medications for Hyperthyroidism Market Size by Geographic Region (2018-2023)
4.1.1 Global Antithyroid Medications for Hyperthyroidism Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Antithyroid Medications for Hyperthyroidism Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Antithyroid Medications for Hyperthyroidism Market Size by Country/Region (2018-2023)
4.2.1 Global Antithyroid Medications for Hyperthyroidism Annual Sales by Country/Region (2018-2023)
4.2.2 Global Antithyroid Medications for Hyperthyroidism Annual Revenue by Country/Region (2018-2023)
4.3 Americas Antithyroid Medications for Hyperthyroidism Sales Growth
4.4 APAC Antithyroid Medications for Hyperthyroidism Sales Growth
4.5 Europe Antithyroid Medications for Hyperthyroidism Sales Growth
4.6 Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Growth
5 Americas
5.1 Americas Antithyroid Medications for Hyperthyroidism Sales by Country
5.1.1 Americas Antithyroid Medications for Hyperthyroidism Sales by Country (2018-2023)
5.1.2 Americas Antithyroid Medications for Hyperthyroidism Revenue by Country (2018-2023)
5.2 Americas Antithyroid Medications for Hyperthyroidism Sales by Type
5.3 Americas Antithyroid Medications for Hyperthyroidism Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antithyroid Medications for Hyperthyroidism Sales by Region
6.1.1 APAC Antithyroid Medications for Hyperthyroidism Sales by Region (2018-2023)
6.1.2 APAC Antithyroid Medications for Hyperthyroidism Revenue by Region (2018-2023)
6.2 APAC Antithyroid Medications for Hyperthyroidism Sales by Type
6.3 APAC Antithyroid Medications for Hyperthyroidism Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antithyroid Medications for Hyperthyroidism by Country
7.1.1 Europe Antithyroid Medications for Hyperthyroidism Sales by Country (2018-2023)
7.1.2 Europe Antithyroid Medications for Hyperthyroidism Revenue by Country (2018-2023)
7.2 Europe Antithyroid Medications for Hyperthyroidism Sales by Type
7.3 Europe Antithyroid Medications for Hyperthyroidism Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antithyroid Medications for Hyperthyroidism by Country
8.1.1 Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales by Country (2018-2023)
8.1.2 Middle East & Africa Antithyroid Medications for Hyperthyroidism Revenue by Country (2018-2023)
8.2 Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales by Type
8.3 Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antithyroid Medications for Hyperthyroidism
10.3 Manufacturing Process Analysis of Antithyroid Medications for Hyperthyroidism
10.4 Industry Chain Structure of Antithyroid Medications for Hyperthyroidism
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antithyroid Medications for Hyperthyroidism Distributors
11.3 Antithyroid Medications for Hyperthyroidism Customer
12 World Forecast Review for Antithyroid Medications for Hyperthyroidism by Geographic Region
12.1 Global Antithyroid Medications for Hyperthyroidism Market Size Forecast by Region
12.1.1 Global Antithyroid Medications for Hyperthyroidism Forecast by Region (2024-2029)
12.1.2 Global Antithyroid Medications for Hyperthyroidism Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antithyroid Medications for Hyperthyroidism Forecast by Type
12.7 Global Antithyroid Medications for Hyperthyroidism Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.1.3 Merck Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Herbrand PharmaChemicals
13.2.1 Herbrand PharmaChemicals Company Information
13.2.2 Herbrand PharmaChemicals Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.2.3 Herbrand PharmaChemicals Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Herbrand PharmaChemicals Main Business Overview
13.2.5 Herbrand PharmaChemicals Latest Developments
13.3 Future Health Pharma
13.3.1 Future Health Pharma Company Information
13.3.2 Future Health Pharma Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.3.3 Future Health Pharma Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Future Health Pharma Main Business Overview
13.3.5 Future Health Pharma Latest Developments
13.4 Shanghai Zhaohui Pharmaceutical
13.4.1 Shanghai Zhaohui Pharmaceutical Company Information
13.4.2 Shanghai Zhaohui Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.4.3 Shanghai Zhaohui Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Shanghai Zhaohui Pharmaceutical Main Business Overview
13.4.5 Shanghai Zhaohui Pharmaceutical Latest Developments
13.5 Beijing Yanjing Pharmaceutical
13.5.1 Beijing Yanjing Pharmaceutical Company Information
13.5.2 Beijing Yanjing Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.5.3 Beijing Yanjing Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Beijing Yanjing Pharmaceutical Main Business Overview
13.5.5 Beijing Yanjing Pharmaceutical Latest Developments
13.6 Jinghua Pharmaceutical Group
13.6.1 Jinghua Pharmaceutical Group Company Information
13.6.2 Jinghua Pharmaceutical Group Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.6.3 Jinghua Pharmaceutical Group Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Jinghua Pharmaceutical Group Main Business Overview
13.6.5 Jinghua Pharmaceutical Group Latest Developments
13.7 Guangzhou Kanghe Pharmaceutical
13.7.1 Guangzhou Kanghe Pharmaceutical Company Information
13.7.2 Guangzhou Kanghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.7.3 Guangzhou Kanghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Guangzhou Kanghe Pharmaceutical Main Business Overview
13.7.5 Guangzhou Kanghe Pharmaceutical Latest Developments
13.8 Zigong Honghe Pharmaceutical
13.8.1 Zigong Honghe Pharmaceutical Company Information
13.8.2 Zigong Honghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.8.3 Zigong Honghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Zigong Honghe Pharmaceutical Main Business Overview
13.8.5 Zigong Honghe Pharmaceutical Latest Developments
13.9 Guangdong Huanan Pharmaceutical
13.9.1 Guangdong Huanan Pharmaceutical Company Information
13.9.2 Guangdong Huanan Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.9.3 Guangdong Huanan Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Guangdong Huanan Pharmaceutical Main Business Overview
13.9.5 Guangdong Huanan Pharmaceutical Latest Developments
13.10 Zibo Wankang Pharmaceutical Chemical
13.10.1 Zibo Wankang Pharmaceutical Chemical Company Information
13.10.2 Zibo Wankang Pharmaceutical Chemical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.10.3 Zibo Wankang Pharmaceutical Chemical Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Zibo Wankang Pharmaceutical Chemical Main Business Overview
13.10.5 Zibo Wankang Pharmaceutical Chemical Latest Developments
13.11 Qilu Pharmaceutical
13.11.1 Qilu Pharmaceutical Company Information
13.11.2 Qilu Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.11.3 Qilu Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Qilu Pharmaceutical Main Business Overview
13.11.5 Qilu Pharmaceutical Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

図表リスト

List of Tables
Table 1. Antithyroid Medications for Hyperthyroidism Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Antithyroid Medications for Hyperthyroidism Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Methimazole
Table 4. Major Players of Propylthiouracil
Table 5. Major Players of Other
Table 6. Global Antithyroid Medications for Hyperthyroidism Sales by Type (2018-2023) & (K Units)
Table 7. Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Type (2018-2023)
Table 8. Global Antithyroid Medications for Hyperthyroidism Revenue by Type (2018-2023) & ($ million)
Table 9. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Type (2018-2023)
Table 10. Global Antithyroid Medications for Hyperthyroidism Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Antithyroid Medications for Hyperthyroidism Sales by Application (2018-2023) & (K Units)
Table 12. Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Application (2018-2023)
Table 13. Global Antithyroid Medications for Hyperthyroidism Revenue by Application (2018-2023)
Table 14. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Application (2018-2023)
Table 15. Global Antithyroid Medications for Hyperthyroidism Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Antithyroid Medications for Hyperthyroidism Sales by Company (2018-2023) & (K Units)
Table 17. Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Company (2018-2023)
Table 18. Global Antithyroid Medications for Hyperthyroidism Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Company (2018-2023)
Table 20. Global Antithyroid Medications for Hyperthyroidism Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Antithyroid Medications for Hyperthyroidism Producing Area Distribution and Sales Area
Table 22. Players Antithyroid Medications for Hyperthyroidism Products Offered
Table 23. Antithyroid Medications for Hyperthyroidism Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Antithyroid Medications for Hyperthyroidism Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Antithyroid Medications for Hyperthyroidism Sales Market Share Geographic Region (2018-2023)
Table 28. Global Antithyroid Medications for Hyperthyroidism Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Antithyroid Medications for Hyperthyroidism Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Country/Region (2018-2023)
Table 32. Global Antithyroid Medications for Hyperthyroidism Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Antithyroid Medications for Hyperthyroidism Sales by Country (2018-2023) & (K Units)
Table 35. Americas Antithyroid Medications for Hyperthyroidism Sales Market Share by Country (2018-2023)
Table 36. Americas Antithyroid Medications for Hyperthyroidism Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Antithyroid Medications for Hyperthyroidism Revenue Market Share by Country (2018-2023)
Table 38. Americas Antithyroid Medications for Hyperthyroidism Sales by Type (2018-2023) & (K Units)
Table 39. Americas Antithyroid Medications for Hyperthyroidism Sales by Application (2018-2023) & (K Units)
Table 40. APAC Antithyroid Medications for Hyperthyroidism Sales by Region (2018-2023) & (K Units)
Table 41. APAC Antithyroid Medications for Hyperthyroidism Sales Market Share by Region (2018-2023)
Table 42. APAC Antithyroid Medications for Hyperthyroidism Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Antithyroid Medications for Hyperthyroidism Revenue Market Share by Region (2018-2023)
Table 44. APAC Antithyroid Medications for Hyperthyroidism Sales by Type (2018-2023) & (K Units)
Table 45. APAC Antithyroid Medications for Hyperthyroidism Sales by Application (2018-2023) & (K Units)
Table 46. Europe Antithyroid Medications for Hyperthyroidism Sales by Country (2018-2023) & (K Units)
Table 47. Europe Antithyroid Medications for Hyperthyroidism Sales Market Share by Country (2018-2023)
Table 48. Europe Antithyroid Medications for Hyperthyroidism Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Antithyroid Medications for Hyperthyroidism Revenue Market Share by Country (2018-2023)
Table 50. Europe Antithyroid Medications for Hyperthyroidism Sales by Type (2018-2023) & (K Units)
Table 51. Europe Antithyroid Medications for Hyperthyroidism Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Antithyroid Medications for Hyperthyroidism Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Antithyroid Medications for Hyperthyroidism Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Antithyroid Medications for Hyperthyroidism
Table 59. Key Market Challenges & Risks of Antithyroid Medications for Hyperthyroidism
Table 60. Key Industry Trends of Antithyroid Medications for Hyperthyroidism
Table 61. Antithyroid Medications for Hyperthyroidism Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Antithyroid Medications for Hyperthyroidism Distributors List
Table 64. Antithyroid Medications for Hyperthyroidism Customer List
Table 65. Global Antithyroid Medications for Hyperthyroidism Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Antithyroid Medications for Hyperthyroidism Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Antithyroid Medications for Hyperthyroidism Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Antithyroid Medications for Hyperthyroidism Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Antithyroid Medications for Hyperthyroidism Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Antithyroid Medications for Hyperthyroidism Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Antithyroid Medications for Hyperthyroidism Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Antithyroid Medications for Hyperthyroidism Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Antithyroid Medications for Hyperthyroidism Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Antithyroid Medications for Hyperthyroidism Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Antithyroid Medications for Hyperthyroidism Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Antithyroid Medications for Hyperthyroidism Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Antithyroid Medications for Hyperthyroidism Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Merck Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 81. Merck Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Herbrand PharmaChemicals Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 85. Herbrand PharmaChemicals Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 86. Herbrand PharmaChemicals Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Herbrand PharmaChemicals Main Business
Table 88. Herbrand PharmaChemicals Latest Developments
Table 89. Future Health Pharma Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 90. Future Health Pharma Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 91. Future Health Pharma Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Future Health Pharma Main Business
Table 93. Future Health Pharma Latest Developments
Table 94. Shanghai Zhaohui Pharmaceutical Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 95. Shanghai Zhaohui Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 96. Shanghai Zhaohui Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Shanghai Zhaohui Pharmaceutical Main Business
Table 98. Shanghai Zhaohui Pharmaceutical Latest Developments
Table 99. Beijing Yanjing Pharmaceutical Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 100. Beijing Yanjing Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 101. Beijing Yanjing Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Beijing Yanjing Pharmaceutical Main Business
Table 103. Beijing Yanjing Pharmaceutical Latest Developments
Table 104. Jinghua Pharmaceutical Group Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 105. Jinghua Pharmaceutical Group Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 106. Jinghua Pharmaceutical Group Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Jinghua Pharmaceutical Group Main Business
Table 108. Jinghua Pharmaceutical Group Latest Developments
Table 109. Guangzhou Kanghe Pharmaceutical Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 110. Guangzhou Kanghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 111. Guangzhou Kanghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Guangzhou Kanghe Pharmaceutical Main Business
Table 113. Guangzhou Kanghe Pharmaceutical Latest Developments
Table 114. Zigong Honghe Pharmaceutical Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 115. Zigong Honghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 116. Zigong Honghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Zigong Honghe Pharmaceutical Main Business
Table 118. Zigong Honghe Pharmaceutical Latest Developments
Table 119. Guangdong Huanan Pharmaceutical Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 120. Guangdong Huanan Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 121. Guangdong Huanan Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Guangdong Huanan Pharmaceutical Main Business
Table 123. Guangdong Huanan Pharmaceutical Latest Developments
Table 124. Zibo Wankang Pharmaceutical Chemical Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 125. Zibo Wankang Pharmaceutical Chemical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 126. Zibo Wankang Pharmaceutical Chemical Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Zibo Wankang Pharmaceutical Chemical Main Business
Table 128. Zibo Wankang Pharmaceutical Chemical Latest Developments
Table 129. Qilu Pharmaceutical Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 130. Qilu Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 131. Qilu Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Qilu Pharmaceutical Main Business
Table 133. Qilu Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Antithyroid Medications for Hyperthyroidism
Figure 2. Antithyroid Medications for Hyperthyroidism Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antithyroid Medications for Hyperthyroidism Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Antithyroid Medications for Hyperthyroidism Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Antithyroid Medications for Hyperthyroidism Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Methimazole
Figure 10. Product Picture of Propylthiouracil
Figure 11. Product Picture of Other
Figure 12. Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Type in 2022
Figure 13. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Type (2018-2023)
Figure 14. Antithyroid Medications for Hyperthyroidism Consumed in Hospital
Figure 15. Global Antithyroid Medications for Hyperthyroidism Market: Hospital (2018-2023) & (K Units)
Figure 16. Antithyroid Medications for Hyperthyroidism Consumed in Clinic
Figure 17. Global Antithyroid Medications for Hyperthyroidism Market: Clinic (2018-2023) & (K Units)
Figure 18. Antithyroid Medications for Hyperthyroidism Consumed in Other
Figure 19. Global Antithyroid Medications for Hyperthyroidism Market: Other (2018-2023) & (K Units)
Figure 20. Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Application (2022)
Figure 21. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Application in 2022
Figure 22. Antithyroid Medications for Hyperthyroidism Sales Market by Company in 2022 (K Units)
Figure 23. Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Company in 2022
Figure 24. Antithyroid Medications for Hyperthyroidism Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Company in 2022
Figure 26. Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Antithyroid Medications for Hyperthyroidism Sales 2018-2023 (K Units)
Figure 29. Americas Antithyroid Medications for Hyperthyroidism Revenue 2018-2023 ($ Millions)
Figure 30. APAC Antithyroid Medications for Hyperthyroidism Sales 2018-2023 (K Units)
Figure 31. APAC Antithyroid Medications for Hyperthyroidism Revenue 2018-2023 ($ Millions)
Figure 32. Europe Antithyroid Medications for Hyperthyroidism Sales 2018-2023 (K Units)
Figure 33. Europe Antithyroid Medications for Hyperthyroidism Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Antithyroid Medications for Hyperthyroidism Revenue 2018-2023 ($ Millions)
Figure 36. Americas Antithyroid Medications for Hyperthyroidism Sales Market Share by Country in 2022
Figure 37. Americas Antithyroid Medications for Hyperthyroidism Revenue Market Share by Country in 2022
Figure 38. Americas Antithyroid Medications for Hyperthyroidism Sales Market Share by Type (2018-2023)
Figure 39. Americas Antithyroid Medications for Hyperthyroidism Sales Market Share by Application (2018-2023)
Figure 40. United States Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Antithyroid Medications for Hyperthyroidism Sales Market Share by Region in 2022
Figure 45. APAC Antithyroid Medications for Hyperthyroidism Revenue Market Share by Regions in 2022
Figure 46. APAC Antithyroid Medications for Hyperthyroidism Sales Market Share by Type (2018-2023)
Figure 47. APAC Antithyroid Medications for Hyperthyroidism Sales Market Share by Application (2018-2023)
Figure 48. China Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Antithyroid Medications for Hyperthyroidism Sales Market Share by Country in 2022
Figure 56. Europe Antithyroid Medications for Hyperthyroidism Revenue Market Share by Country in 2022
Figure 57. Europe Antithyroid Medications for Hyperthyroidism Sales Market Share by Type (2018-2023)
Figure 58. Europe Antithyroid Medications for Hyperthyroidism Sales Market Share by Application (2018-2023)
Figure 59. Germany Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Antithyroid Medications for Hyperthyroidism Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Market Share by Application (2018-2023)
Figure 68. Egypt Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Antithyroid Medications for Hyperthyroidism in 2022
Figure 74. Manufacturing Process Analysis of Antithyroid Medications for Hyperthyroidism
Figure 75. Industry Chain Structure of Antithyroid Medications for Hyperthyroidism
Figure 76. Channels of Distribution
Figure 77. Global Antithyroid Medications for Hyperthyroidism Sales Market Forecast by Region (2024-2029)
Figure 78. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Antithyroid Medications for Hyperthyroidism Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Antithyroid Medications for Hyperthyroidism Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share Forecast by Application (2024-2029)